Avlar BioVentures Overview
- Investor Type
-
Venture Capital
- Status
-
Inactive
- Investments
-
35
- Portfolio
-
1
- Exits
-
22
Avlar BioVentures General Information
Company Description
Avlar BioVentures was a Cambridge, United Kingdom based venture capital firm. The firm primarily makes early stage and seed investments and targets the biotechnology and healthcare sectors.
Business Details
Website
www.avlar.comYear Founded
Investor Status
Primary Investor Type
Corporate Office
- Highfield Court
- Madingley
- Cambridge CB23 8AG
- England, United Kingdom
Avlar BioVentures Investments (35)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Crescendo Biologics | 05-Oct-2012 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 1 | ||
| TeraView | 23-Dec-2011 | Electronic Equipment and Instruments | Generating Revenue | |||
| Amura (Drug Discovery) | 31-Jan-2011 | Drug Discovery | Out of Business | |||
| Crescendo Biologics | 12-Oct-2009 | Drug Discovery | Clinical Trials - Phase 1 | |||
| York Pharma | 01-Oct-2008 | Distributors (Healthcare) | Out of Business | |||
| Medical Device Innovations | 11-Mar-2008 | Therapeutic Devices | Out of Business | |||
| Medical Device Innovations | 01-Mar-2007 | Therapeutic Devices | Out of Business | |||
| De Novo Pharmaceuticals | 31-Dec-2006 | Drug Discovery | Generating Revenue | |||
| CellCentric | 18-Jul-2006 | Early Stage VC | Drug Discovery | Clinical Trials - Phase 1 | ||
| Paradigm Therapeutics. | 07-Jul-2006 | Later Stage VC | Drug Discovery | Generating Revenue |
Avlar BioVentures Exits (22)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| TeraView | 08-Dec-2025 | IPO | |
| Paion | 26-Oct-2023 | ||
| Crescendo Biologics | 24-Jul-2023 | ||
| De Novo Pharmaceuticals | 01-Apr-2021 | ||
| Amura (Drug Discovery) | 01-Nov-2017 | ||
| Medical Device Innovations | 01-Jun-2014 | ||
| NXVision | 15-Sep-2010 | ||
| Purely Proteins | 16-Jul-2010 | ||
| Intercytex | 30-Jun-2010 | IPO | |
| Aitua | 01-Mar-2010 | Out of Business |
Avlar BioVentures Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
Avlar BioVentures Investments by Industry, Year, and Region
Avlar BioVentures Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Aclardian | Cambridge, United Kingdom | 2008 |
Avlar BioVentures FAQs
-
What is Avlar BioVentures?
Avlar BioVentures was a Cambridge, United Kingdom based venture capital firm.
-
When was Avlar BioVentures founded?
Avlar BioVentures was founded in 1999.
-
Where is Avlar BioVentures headquartered?
Avlar BioVentures is headquartered in Cambridge, United Kingdom.
-
How many investments has Avlar BioVentures made?
Avlar BioVentures has made 35 investments.
-
What has Avlar BioVentures invested in?
Avlar BioVentures has made numerous investments in companies like Crescendo Biologics, TeraView, and Amura (Drug Discovery) within the Drug Discovery and Electronic Equipment and Instruments industries.
-
What has Avlar BioVentures invested in recently?
Avlar BioVentures's latest investment was on 05-Oct-2012 in Crescendo Biologics, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process